BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 7622647)

  • 21. Poison ivy dermatitis. Nuances in treatment.
    Williford PM; Sheretz EF
    Arch Fam Med; 1994 Feb; 3(2):184-8. PubMed ID: 7994440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of antigen specific hyposensitization to poison oak in sensitized adults.
    Epstein WL; Byers VS; Frankart W
    Arch Dermatol; 1982 Sep; 118(9):630-3. PubMed ID: 6180687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
    Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
    Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urushiol Patch Test Using the T.R.U.E. TEST System.
    Kim Y; Longenecker A; ElSohly MA; Gul W; Hage RJ; Hamann CP; Marks JG
    Dermatitis; 2018; 29(3):127-131. PubMed ID: 29762206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poison ivy/oak dermatitis. Use of polyamine salts of a linoleic acid dimer for topical prophylaxis.
    Orchard S; Fellman JH; Storrs FJ
    Arch Dermatol; 1986 Jul; 122(7):783-9. PubMed ID: 2942115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poison ivy, poison oak, and poison sumac. Common causes of occupational dermatitis.
    Gellin GA; Wolf CR; Milby TH
    Arch Environ Health; 1971 Feb; 22(2):280-6. PubMed ID: 4250362
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of various barrier preparations in preventing and/or ameliorating experimentally produced Toxicodendron dermatitis.
    Grevelink SA; Murrell DF; Olsen EA
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):182-8. PubMed ID: 1430354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of poison oak dermatitis treated with Grindelia spp. (Gumweed).
    Canavan D; Yarnell E
    J Altern Complement Med; 2005 Aug; 11(4):709-10. PubMed ID: 16131296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urushiol detection using a profluorescent nitroxide.
    Braslau R; Rivera F; Lilie E; Cottman M
    J Org Chem; 2013 Jan; 78(2):238-45. PubMed ID: 22900824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy.
    Liu B; Tai Y; Achanta S; Kaelberer MM; Caceres AI; Shao X; Fang J; Jordt SE
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7572-E7579. PubMed ID: 27821781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical substances which prevent poison ivy allergic contact dermatitis.
    Orchard SM; Fellman JH; Storrs FJ
    Acta Derm Venereol Suppl (Stockh); 1987; 134():103-6. PubMed ID: 2965482
    [No Abstract]   [Full Text] [Related]  

  • 32. A study of cross-reactions between mango contact allergens and urushiol.
    Oka K; Saito F; Yasuhara T; Sugimoto A
    Contact Dermatitis; 2004; 51(5-6):292-6. PubMed ID: 15606656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it, or isn't it? Poison ivy look-a-likes.
    McGovern TW; LaWarre SR; Brunette C
    Am J Contact Dermat; 2000 Jun; 11(2):104-10. PubMed ID: 10908180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contact allergy to Anacardiaceae. A review and case reports of poison ivy allergy in central Europe].
    Ippen H
    Derm Beruf Umwelt; 1983; 31(5):140-8. PubMed ID: 6227468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CONTACT DERMATITIS CAUSED BY POISON IVY, POISON SUMAC AND POISON OAK.
    PERLMAN HH
    Med Sci; 1964 Aug; 15():31-41. PubMed ID: 14180800
    [No Abstract]   [Full Text] [Related]  

  • 36. Algerian ivy dermatitis; a California disease.
    DORSEY CS
    Calif Med; 1959 Feb; 90(2):155-9. PubMed ID: 13629356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.
    Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The feasibility of using skin protectant products and education to prevent poison oak.
    Scott MJ; Heumann MA; DeBruyckere DM; Brundage TW; Kohn MA
    Wilderness Environ Med; 2002; 13(3):206-8. PubMed ID: 12353598
    [No Abstract]   [Full Text] [Related]  

  • 39. A pilot study of pentoxifylline for the prevention of poison ivy/oak reactions.
    Rietschel RL
    Contact Dermatitis; 1995 Jun; 32(6):365-6. PubMed ID: 7554891
    [No Abstract]   [Full Text] [Related]  

  • 40. The effectiveness of jewelweed, Impatiens capensis, the related cultivar I. balsamina and the component, lawsone in preventing post poison ivy exposure contact dermatitis.
    Abrams Motz V; Bowers CP; Mull Young L; Kinder DH
    J Ethnopharmacol; 2012 Aug; 143(1):314-8. PubMed ID: 22766473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.